The results of this pilot study indicate safety and effectiveness of repetitive transcranial stimulation (rTMS) directed to the right prefrontal cortex (rPFC) for the treatment of adults with attention deficit hyperactivity disorder (ADHD).
Why this matters
One-third of adult patients with ADHD find current pharmacological treatment either ineffective or intolerable and seek other, non-pharmacological alternatives.
This study suggests a safe, theoretically motivated, pathophysiologically relevant,
non-pharmacological treatment to alleviate symptoms in adult patients with ADHD.